Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure

Blood (2023) 142 (26): 2305–2314.

https://doi.org/10.1182/blood.2023022136

Published: 2023

Includes: Supplemental data

Journal Articles

ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia

Blood (2022) 140 (3): 274–284.

https://doi.org/10.1182/blood.2021014240

Published: 2022

Includes: Supplemental data

Journal Articles

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia

Blood (2021) 138 (22): 2256–2268.

https://doi.org/10.1182/blood.2021013231

Published: 2021

Includes: Supplemental data

Journal Articles

Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein

Blood (2021) 138 (14): 1269–1277.

https://doi.org/10.1182/blood.2021012938

Published: 2021

Includes: Supplemental data

Journal Articles

Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2

Thomas Thiele, Lena Ulm, Silva Holtfreter, Linda Schönborn, Sven Olaf Kuhn, Christian Scheer, Theodore E. Warkentin, Barbara M. Bröker, Karsten Becker, Konstanze Aurich, Kathleen Selleng, Nils-Olaf Hübner, Andreas Greinacher

Blood (2021) 138 (4): 299–303.

https://doi.org/10.1182/blood.2021012217

Published: 2021

Journal Articles

Genome-Wide Association Study Identifies Variation in ABO As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia

Jason B Giles, Jérôme Rollin, PhD, Christian M Shaffer, Heidi E Steiner, Yukihide Momozawa, DVM,PhD, Ian Stanaway, PhD, Taisei Mushiroda, Claire Pouplard, PharmD, PhD, Nancy Heddle, MSc, Michiaki Kubo, MDPhD, Elizabeth Phillips, MD, Theodore E. Warkentin, MD, Yves Gruel, MD PhD, Andreas Greinacher, MD, Dan Roden, MD, Jason Karnes, PhDPharmD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-139651

Published: 2020

Journal Articles

HIT: still stringing us along

Theodore E. Warkentin

Blood (2020) 135 (15): 1193–1194.

https://doi.org/10.1182/blood.2020005157

Published: 2020

Journal Articles

Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT

Krystin Krauel, Patricia Preuße, Theodore E. Warkentin, Catja Trabhardt, Sven Brandt, Inga Jensch, Martin Mandelkow, Elke Hammer, Sven Hammerschmidt, Andreas Greinacher

Blood (2019) 133 (9): 978–989.

https://doi.org/10.1182/blood-2018-05-850370

Published: 2019

Includes: Supplemental data

Journal Articles

Natural, not immune; classical, not alternative

Theodore E. Warkentin

Blood (2018) 132 (23): 2421–2422.

https://doi.org/10.1182/blood-2018-10-880799

Published: 2018

Journal Articles

High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT

Theodore E. Warkentin, Jo-Ann I. Sheppard, Lori-Ann Linkins, Donald M. Arnold, Ishac Nazy

Blood (2018) 132 (12): 1345–1349.

https://doi.org/10.1182/blood-2018-04-847483

Published: 2018

Journal Articles

Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma

Hira Mian, Theodore E. Warkentin, Jo-Ann I. Sheppard, Anna MacDonald, Lori-Ann Linkins, Ann Benger, Ronan Foley

Blood (2017) 130 (14): 1679–1682.

https://doi.org/10.1182/blood-2017-06-788679

Published: 2017

Journal Articles

Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review

Theodore E. Warkentin, Menaka Pai, Lori-Ann Linkins

Blood (2017) 130 (9): 1104–1113.

https://doi.org/10.1182/blood-2017-04-778993

Published: 2017

Journal Articles

B cells, PF4/heparin complexes, and complement

Theodore E. Warkentin

Blood (2016) 128 (14): 1781–1782.

https://doi.org/10.1182/blood-2016-08-729517

Published: 2016

Journal Articles

How I treat patients with a history of heparin-induced thrombocytopenia

Theodore E. Warkentin, Julia A. M. Anderson

Blood (2016) 128 (3): 348–359.

https://doi.org/10.1182/blood-2016-01-635003

Published: 2016

Journal Articles

Knee replacement and HIT without heparin

Theodore E. Warkentin

Blood (2016) 127 (8): 961–962.

https://doi.org/10.1182/blood-2015-12-687665

Published: 2016

Journal Articles

Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study

Lori Ann Linkins, MD MSc, FRCPC, Theodore E. Warkentin, MD, Menaka Pai, MD MSc, FRCP(C), Sudeep Shivakumar, MD, Rizwan Manji, MD PhD MBA, Philip S Wells, MD FRCPC, MSc, Cynthia M Wu, MD FRCPC, Ishac Nazi, PhD, Mark A. Crowther, MD MSc, FRCPC

Blood (2015) 126 (23): 3468.

https://doi.org/10.1182/blood.V126.23.3468.3468

Published: 2015

Journal Articles

Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study

Lori-Ann Linkins, Shannon M. Bates, Agnes Y. Y. Lee, Nancy M. Heddle, Grace Wang, Theodore E. Warkentin

Blood (2015) 126 (5): 597–603.

https://doi.org/10.1182/blood-2014-12-618165

Published: 2015

Journal Articles

Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome

Theodore E. Warkentin, Richard J. Cook, Ravi Sarode, Debi A. Sloane, Mark A. Crowther

Blood (2015) 126 (4): 486–493.

https://doi.org/10.1182/blood-2015-01-622787

Published: 2015

Journal Articles

Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities

Theodore E. Warkentin, Jo-Ann I. Sheppard, F. Victor Chu, Anil Kapoor, Mark A. Crowther, Azim Gangji

Blood (2015) 125 (1): 195–198.

https://doi.org/10.1182/blood-2014-07-590844

Published: 2015

Journal Articles

Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study

Mary Salib, MD, Robert Clayden, Rumi Clare, B.Sc., Grace Wang, MMath, Theodore E. Warkentin, MD, Mark A. Crowther, MD, Wendy Lim, MD MSc., FRCPC, Donald M. Arnold, MD MSc

Blood (2014) 124 (21): 3521.

https://doi.org/10.1182/blood.V124.21.3521.3521

Published: 2014

NARROW

Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure

ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia

Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein

Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2

Genome-Wide Association Study Identifies Variation in ABO As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia

HIT: still stringing us along

Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT

Natural, not immune; classical, not alternative

High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT

Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma

Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review

B cells, PF4/heparin complexes, and complement

How I treat patients with a history of heparin-induced thrombocytopenia

Knee replacement and HIT without heparin

Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study

Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study

Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome

Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities

Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only